Identification of rare, single-nucleotide mutations in NDE1 and their contributions to schizophrenia susceptibility

Schizophrenia Bulletin

Volumn 41, Issue 3, 2015, Pages 744-753

  Kimura, Hiroki ^a   Tsuboi, Daisuke ^a   Wang, Chenyao ^a   Kushima, Itaru ^a   Koide, Takayoshi ^a   Ikeda, Masashi ^b   Iwayama, Yoshimi ^c   Toyota, Tomoko ^c   Yamamoto, Noriko ^d   Kunimoto, Shohko ^a   Nakamura, Yukako ^a   Yoshimi, Akira ^a   Banno, Masahiro ^a   Xing, Jingrui ^a   Takasaki, Yuto ^a   Yoshida, Mami ^a   Aleksic, Branko ^a   Uno, Yota ^a   Okada, Takashi ^a   Iidaka, Tetsuya ^a   Inada, Toshiya ^e   Suzuki, Michio ^f   Ujike, Hiroshi ^g   Kunugi, Hiroshi ^d   Kato, Tadafumi ^c   Yoshikawa, Takeo ^c   Iwata, Nakao ^b   Kaibuchi, Kozo ^a   Ozaki, Norio ^a   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^e SEIWA HOSPITAL   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

^g Ujike Nishiguchi Clinic   (Japan)

Author keywords

DISC1; Protein protein interaction; Rare variants; SNV; Target resequencing; YWHAE

Indexed keywords

COMPLEMENTARY DNA; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; GENOMIC DNA; NUCLEAR DISTRIBUTION E HOMOLOG 1; PHOSPHOPROTEIN; PROTEIN VARIANT; REGULATOR PROTEIN; S214F PROTEIN; UNCLASSIFIED DRUG; YWHAE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NDE1 PROTEIN, HUMAN;

ADULT; ARTICLE; AUTISM; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MOLECULAR PHYLOGENY; NERVE FIBER GROWTH; NEUROPATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; EXON; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

ADULT; BIPOLAR DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84930538918     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu147     Document Type: Article

References (58)

1. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475:27-30.
2. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187-1192.
3. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234-239.
4. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13:537-551.
5. Ripke S, O'Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150-1159.
6. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223-1241.
7. Timms AE, Dorschner MO, Wechsler J, et al. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry. 2013;70:582-590.
8. Hamilton PJ, Campbell NG, Sharma S, et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry. 2013;18:1315-1323.
9. Mondal K, Ramachandran D, Patel VC, et al. Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder. Hum Mol Genet. 2012;21:4356-4364.
10. Durand CM, Perroy J, Loll F, et al. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry. 2012;17:71-84.
11. Szatkiewicz JP, O'Dushlaine C, Chen G, et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry. 2014;19:762-773.
12. Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506:185-190.
13. Moessner R, Marshall CR, Sutcliffe JS, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007;81:1289-1297.
14. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39:25-27.
15. Bonaglia MC, Giorda R, Borgatti R, et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet. 2001;69:261-268.
16. Ullmann R, Turner G, Kirchhoff M, et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat. 2007;28:674-682.
17. Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet. 2010;6:e1000962.
18. Heinzen EL, Radtke RA, Urban TJ, et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet. 2010;86:707-718.
19. de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133:23-32.
20. Ingason A, Rujescu D, Cichon S, et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry. 2011;16:17-25.
21. Ikeda M, Aleksic B, Kirov G, et al. Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry. 2010;67:283-286.
22. Kirov G, Grozeva D, Norton N, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009;18:1497-1503.
23. Nagamani SC, Erez A, Bader P, et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet. 2011;19:280-286.
24. Hannes FD, Sharp AJ, Mefford HC, et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet. 2009;46:223-232.
25. Williams NM, Norton N, Williams H, et al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet. 2003;73:1355-1367.
26. International Molecular Genetic Study of Autism C. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet. 2001;69:570-581.
27. Lamb JA, Barnby G, Bonora E, et al. Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet. 2005;42:132-137.
28. Bakircioglu M, Carvalho OP, Khurshid M, et al. The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. Am J Hum Genet. 2011;88:523-535.
29. Feng Y, Walsh CA. Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron. 2004;44:279-293.
30. Tarricone C, Perrina F, Monzani S, et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. Neuron. 2004;44:809-821.
31. Hirohashi Y, Wang Q, Liu Q, et al. Centrosomal proteins Nde1 and Su48 form a complex regulated by phosphorylation. Oncogene. 2006;25:6048-6055.
32. Alkuraya FS, Cai X, Emery C, et al. Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]. Am J Hum Genet. 2011;88:536-547.
33. Hennah W, Tomppo L, Hiekkalinna T, et al. Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet. 2007;16:453-462.
34. Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011;12:707-722.
35. Efimov VP, Morris NR. The LIS1-related NUDF protein of Aspergillus nidulans interacts with the coiled-coil domain of the NUDE/RO11 protein. J Cell Biol. 2000;150:681-688.
36. Bradshaw NJ, Christie S, Soares DC, et al. NDE1 and NDEL1: multimerisation, alternate splicing and DISC1 interaction. Neurosci Lett. 2009;449:228-233.
37. Burdick KE, Kamiya A, Hodgkinson CA, et al. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum Mol Genet. 2008;17:2462-2473.
38. Toyo-oka K, Shionoya A, Gambello MJ, et al. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet. 2003;34:274-285.
39. Ikeda M, Hikita T, Taya S, et al. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet. 2008;17:3212-3222.
40. Ikeda M, Aleksic B, Kinoshita Y, et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry. 2011;69:472-478.
41. Dong C, Yu B. Mutation surveyor: an in silico tool for sequencing analysis. Methods Mol Biol. 2011;760:223-237.
42. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249.
43. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073-1081.
44. Ferrer-Costa C, Gelpi JL, Zamakola L, et al. PMUT: a webbased tool for the annotation of pathological mutations on proteins. Bioinformatics. 2005;21:3176-3178.
45. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
46. Funahashi Y, Namba T, Fujisue S, et al. ERK2-mediated phosphorylation of Par3 regulates neuronal polarization. J Neurosci. 2013;33:13270-13285.
47. Taya S, Shinoda T, Tsuboi D, et al. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci. 2007;27:15-26.
48. Bradshaw NJ, Soares DC, Carlyle BC, et al. PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. J Neurosci. 2011;31:9043-9054.
49. Soares DC, Bradshaw NJ, Zou J, et al. The mitosis and neurodevelopment proteins NDE1 and NDEL1 form dimers, tetramers, and polymers with a folded back structure in solution. J Biol Chem. 2012;287:32381-32393.
50. Wang X, Wei X, Thijssen B, et al. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol. 2012;30:159-164.
51. Kang HJ, Kawasawa YI, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011;478:483-489.
52. Soukoulis V, Reddy S, Pooley RD, et al. Cytoplasmic LEK1 is a regulator of microtubule function through its interaction with the LIS1 pathway. Proc Natl Acad Sci U S A. 2005;102:8549-8554.
53. Toyo-Oka K, Sasaki S, Yano Y, et al. Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration. Hum Mol Genet. 2005;14:3113-3128.
54. Piva F, Giulietti M, Burini AB, et al. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat. 2012;33:81-85.
55. Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003;73:1157-1161.
56. Smoller JW, Craddock N, Kendler K, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371-1379.
57. Williams HJ, Craddock N, Russo G, et al. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet. 2011;20:387-391.
58. Bradshaw NJ, Ogawa F, Antolin-Fontes B, et al. DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem Biophys Res Commun. 2008;377:1091-1096.